CN114668044A - 一种婴幼儿配方绵羊奶粉 - Google Patents
一种婴幼儿配方绵羊奶粉 Download PDFInfo
- Publication number
- CN114668044A CN114668044A CN202011548938.9A CN202011548938A CN114668044A CN 114668044 A CN114668044 A CN 114668044A CN 202011548938 A CN202011548938 A CN 202011548938A CN 114668044 A CN114668044 A CN 114668044A
- Authority
- CN
- China
- Prior art keywords
- parts
- oligosaccharide
- sheep milk
- milk powder
- sheep
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 35
- 235000020254 sheep milk Nutrition 0.000 title claims abstract description 31
- 235000013350 formula milk Nutrition 0.000 claims abstract description 36
- 235000020256 human milk Nutrition 0.000 claims abstract description 18
- 210000004251 human milk Anatomy 0.000 claims abstract description 18
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 15
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 15
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 34
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 32
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 17
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 17
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 17
- 235000010755 mineral Nutrition 0.000 claims description 17
- 239000011707 mineral Substances 0.000 claims description 17
- 229940114079 arachidonic acid Drugs 0.000 claims description 16
- 235000021342 arachidonic acid Nutrition 0.000 claims description 16
- 229940088594 vitamin Drugs 0.000 claims description 14
- 229930003231 vitamin Natural products 0.000 claims description 14
- 235000013343 vitamin Nutrition 0.000 claims description 14
- 239000011782 vitamin Substances 0.000 claims description 14
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 12
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 12
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 11
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 9
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 9
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 9
- 239000008101 lactose Substances 0.000 claims description 9
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 241001494479 Pecora Species 0.000 claims description 8
- 239000005862 Whey Substances 0.000 claims description 8
- 102000007544 Whey Proteins Human genes 0.000 claims description 8
- 108010046377 Whey Proteins Proteins 0.000 claims description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 8
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 8
- 239000008158 vegetable oil Substances 0.000 claims description 8
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 6
- 239000004615 ingredient Substances 0.000 claims description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 6
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 4
- 229960000304 folic acid Drugs 0.000 claims description 4
- 235000019152 folic acid Nutrition 0.000 claims description 4
- 239000011724 folic acid Substances 0.000 claims description 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 3
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 3
- 235000019743 Choline chloride Nutrition 0.000 claims description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 3
- 235000000638 D-biotin Nutrition 0.000 claims description 3
- 239000011665 D-biotin Substances 0.000 claims description 3
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 claims description 3
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 claims description 3
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 3
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 3
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- 235000010216 calcium carbonate Nutrition 0.000 claims description 3
- 239000001506 calcium phosphate Substances 0.000 claims description 3
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 3
- 229960003178 choline chloride Drugs 0.000 claims description 3
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 3
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 3
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 3
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 3
- 239000011666 cyanocobalamin Substances 0.000 claims description 3
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 3
- 239000011790 ferrous sulphate Substances 0.000 claims description 3
- 235000003891 ferrous sulphate Nutrition 0.000 claims description 3
- 229960000367 inositol Drugs 0.000 claims description 3
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 3
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 3
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 3
- 235000012680 lutein Nutrition 0.000 claims description 3
- 239000001656 lutein Substances 0.000 claims description 3
- 229960005375 lutein Drugs 0.000 claims description 3
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 3
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 3
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 3
- 229940099596 manganese sulfate Drugs 0.000 claims description 3
- 239000011702 manganese sulphate Substances 0.000 claims description 3
- 235000007079 manganese sulphate Nutrition 0.000 claims description 3
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 235000019175 phylloquinone Nutrition 0.000 claims description 3
- 239000011772 phylloquinone Substances 0.000 claims description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 3
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 claims description 3
- 229960001898 phytomenadione Drugs 0.000 claims description 3
- 239000001103 potassium chloride Substances 0.000 claims description 3
- 235000011164 potassium chloride Nutrition 0.000 claims description 3
- 239000001508 potassium citrate Substances 0.000 claims description 3
- 229960002635 potassium citrate Drugs 0.000 claims description 3
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 3
- 235000011082 potassium citrates Nutrition 0.000 claims description 3
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 3
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 3
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 3
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 3
- 229960000342 retinol acetate Drugs 0.000 claims description 3
- 235000019173 retinyl acetate Nutrition 0.000 claims description 3
- 239000011770 retinyl acetate Substances 0.000 claims description 3
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 3
- 229960002477 riboflavin Drugs 0.000 claims description 3
- 235000019192 riboflavin Nutrition 0.000 claims description 3
- 239000002151 riboflavin Substances 0.000 claims description 3
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 3
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 3
- 229960005055 sodium ascorbate Drugs 0.000 claims description 3
- 239000001509 sodium citrate Substances 0.000 claims description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 3
- 235000011083 sodium citrates Nutrition 0.000 claims description 3
- 239000011781 sodium selenite Substances 0.000 claims description 3
- 235000015921 sodium selenite Nutrition 0.000 claims description 3
- 229960001471 sodium selenite Drugs 0.000 claims description 3
- 229960003080 taurine Drugs 0.000 claims description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 3
- 229960000344 thiamine hydrochloride Drugs 0.000 claims description 3
- 235000019190 thiamine hydrochloride Nutrition 0.000 claims description 3
- 239000011747 thiamine hydrochloride Substances 0.000 claims description 3
- 229940042585 tocopherol acetate Drugs 0.000 claims description 3
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 3
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 3
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 3
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 3
- 235000005282 vitamin D3 Nutrition 0.000 claims description 3
- 239000011647 vitamin D3 Substances 0.000 claims description 3
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 3
- 229940021056 vitamin d3 Drugs 0.000 claims description 3
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 3
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 3
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 3
- 229960001763 zinc sulfate Drugs 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 abstract description 14
- 239000008267 milk Substances 0.000 abstract description 14
- 210000004080 milk Anatomy 0.000 abstract description 14
- 230000012010 growth Effects 0.000 abstract description 10
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 235000013406 prebiotics Nutrition 0.000 abstract description 4
- 239000006041 probiotic Substances 0.000 abstract description 3
- 235000018291 probiotics Nutrition 0.000 abstract description 3
- 238000001727 in vivo Methods 0.000 abstract description 2
- 230000007413 intestinal health Effects 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 15
- 238000011161 development Methods 0.000 description 7
- 206010051606 Necrotising colitis Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 235000020251 goat milk Nutrition 0.000 description 6
- 208000004995 necrotizing enterocolitis Diseases 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 201000006195 perinatal necrotizing enterocolitis Diseases 0.000 description 6
- 238000004945 emulsification Methods 0.000 description 5
- 230000009102 absorption Effects 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 102000014171 Milk Proteins Human genes 0.000 description 3
- 108010011756 Milk Proteins Proteins 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 102000009366 Alpha-s1 casein Human genes 0.000 description 2
- 108050000244 Alpha-s1 casein Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 208000019637 Infantile Diarrhea Diseases 0.000 description 2
- 102000010445 Lactoferrin Human genes 0.000 description 2
- 108010063045 Lactoferrin Proteins 0.000 description 2
- 102000008192 Lactoglobulins Human genes 0.000 description 2
- 108010060630 Lactoglobulins Proteins 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 239000013566 allergen Substances 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 235000008452 baby food Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000021242 lactoferrin Nutrition 0.000 description 2
- 229940078795 lactoferrin Drugs 0.000 description 2
- 235000021239 milk protein Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- CILYIEBUXJIHCO-UHFFFAOYSA-N 102778-91-6 Natural products O1C(C(O)C(O)CO)C(NC(=O)C)C(O)CC1(C(O)=O)OC1C(O)C(OC2C(C(O)C(O)OC2CO)O)OC(CO)C1O CILYIEBUXJIHCO-UHFFFAOYSA-N 0.000 description 1
- DVGKRPYUFRZAQW-UHFFFAOYSA-N 3 prime Natural products CC(=O)NC1OC(CC(O)C1C(O)C(O)CO)(OC2C(O)C(CO)OC(OC3C(O)C(O)C(O)OC3CO)C2O)C(=O)O DVGKRPYUFRZAQW-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000589875 Campylobacter jejuni Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000186779 Listeria monocytogenes Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- CILYIEBUXJIHCO-UITFWXMXSA-N N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose Chemical compound O1[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(=O)C)[C@@H](O)C[C@@]1(C(O)=O)O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)O[C@@H]2CO)O)O[C@H](CO)[C@@H]1O CILYIEBUXJIHCO-UITFWXMXSA-N 0.000 description 1
- OIZGSVFYNBZVIK-UHFFFAOYSA-N N-acetylneuraminosyl-D-lactose Natural products O1C(C(O)C(O)CO)C(NC(=O)C)C(O)CC1(C(O)=O)OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1O OIZGSVFYNBZVIK-UHFFFAOYSA-N 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- FCIROHDMPFOSFG-LAVSNGQLSA-N disialyllacto-N-tetraose Chemical compound O1[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(=O)C)[C@@H](O)C[C@@]1(C(O)=O)OC[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@]3(O[C@H]([C@H](NC(C)=O)[C@@H](O)C3)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](NC(C)=O)[C@H](O[C@@H]2[C@H]([C@H](O[C@H]3[C@@H]([C@@H](O)C(O)O[C@@H]3CO)O)O[C@H](CO)[C@@H]2O)O)O1 FCIROHDMPFOSFG-LAVSNGQLSA-N 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000000369 enteropathogenic effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000020610 powder formula Nutrition 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1528—Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/158—Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biophysics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及婴幼儿配方奶粉，具体涉及一种婴幼儿配方绵羊奶粉。其方案含有如下重量份配比的成分：脂绵羊乳2200‑3000份，绵羊脱盐乳清粉50‑220份，乳糖200‑320份，植物油80‑140份，低聚果糖10‑14份、低聚半乳糖19‑26份、母乳低聚糖25‑40份，DHA(二十二碳六烯酸)3.5‑5份、ARA(花生四烯酸)4.5‑8.5份、维生素4‑6份、矿物质10‑13份。本发明所添加的FOS和GOS益生元组合及一种母乳低聚糖，有助于婴幼儿的肠道健康，促进体内的益生菌的生长和平衡。
Description
技术领域
本发明涉及配方奶粉，具体涉及一种婴幼儿配方绵羊奶粉。
背景技术
母乳含有婴幼儿生长发育的全部营养素，因此现代社会都提倡母乳喂养。但是目前我国的婴幼儿母乳喂养率仅在35％左右，大多数还是要依靠婴幼儿配方奶粉来提供生长发育的营养成分，由于母乳的优越性，婴幼儿配方奶的目前一直是尽量模拟母乳。母乳的成分主要可以分为两大类，营养性成分和功能性成分。营养性成分主要是指为人体提供能量，比如乳糖、脂肪和蛋白质；而功能性成分则是指调节人体免疫机能、参与某些组织的修复的成分，比如，免疫球蛋白、乳铁蛋白、低聚糖、神经节苷脂等。现阶段婴幼儿配方食品在模拟母乳的研究上主要集中于蛋白质、脂肪的结构组成趋于母乳化，而对于功能性成分母乳化的研究则相对较少。对母乳成分生理功能特性的深入了解,有助于更加完善婴儿食品的研制。在制备婴儿配方食品时,不仅要考虑其营养功能，同时也应注重其所具有的生物学意义,这也是婴幼儿食品的一个重要的研究方向。
婴幼儿配方乳粉的发展是以科学为基础的从组成到功能模拟的研发历程，从最初的能量、营养素含量模拟到第二代添加DHA/AA促进神经系统/视力/认知发育，再到现阶段最多的模拟母乳添加结构脂OPO、益生菌+益生元促进肠道功能，提升免疫力的配方，都是主要集中于结构组成母乳化，而对功能性成分母乳化的研究则较少。现有市面上的奶粉的主要缺点：1.配方奶粉中益生元不够母乳化(目前市场上采用的低聚糖都是低聚果糖和低聚半乳糖，并没有精准模拟母乳低聚糖，更没有绵羊奶与母乳低聚糖的结合)。2.市场产品没有特定提高免疫力和肠胃道动力配方，宝宝很容易腹泻，免疫力下降，患有各种疾病(本专利内容结合纯绵羊乳蛋白、母乳低聚糖、益生元组成一款保护宝宝肠胃健康和提高抵抗力的配方)。3.市场上婴幼儿配方乳粉产品大多数是添加牛乳蛋白(包括羊奶粉配方产品)，牛奶中的某些蛋白质如α-s1酪蛋白和β- 乳球蛋白是目前公认的过敏原，很容易造成婴幼儿过敏。4.配方不够亲和婴幼儿，不够从整体层面上母乳化。
发明内容
本发明是采用绵羊乳为基础原料开发的新婴幼儿配方奶粉，其方案如下：
一种婴幼儿配方绵羊奶粉，含有如下重量份配比的成分：全脂绵羊乳2200-3000份，绵羊脱盐乳清粉50-220份，乳糖200-320份，植物油 80-140份，低聚果糖10-14份、低聚半乳糖19-26份、母乳低聚糖25-40 份，DHA(二十二碳六烯酸)3.5-5份、ARA(花生四烯酸)4.5-8.5 份、维生素4-6份、矿物质10-13份。
本发明的另一优选方案是，一种婴幼儿配方绵羊奶粉，含有如下重量份配比的成分：全脂绵羊乳2500-2800份，绵羊脱盐乳清粉100-150 份，乳糖240-280份，植物油100-120份，低聚果糖12-13份、低聚半乳糖20-24份、DHA(二十二碳六烯酸)4-4.5份、ARA(花生四烯酸)5-7 份、维生素4-6份、矿物质11-12份。
本发明的另一优选方案是，一种婴幼儿配方绵羊奶粉，含有如下重量份配比的成分：全脂绵羊乳2500-2800份，绵羊脱盐乳清粉100-150 份，乳糖240-280份，植物油100-120份，低聚果糖12-13份、低聚半乳糖20-24份、DHA(二十二碳六烯酸)4-4.5份、ARA(花生四烯酸)5-7 份、维生素4-6份、矿物质11-12份。
本发明的另一优选方案是，一种婴幼儿配方绵羊奶粉，含有如下重量份配比的成分：全脂绵羊乳2700份，绵羊脱盐乳清粉120份，乳糖260 份，植物油110份，低聚果糖12.8份、低聚半乳糖23份、DHA(二十二碳六烯酸)4.4份、ARA(花生四烯酸)6.5份、维生素5份、矿物质11.9 份。
本发明的另一优选方案是，所述维生素为以下成分混合而成：L-抗坏血酸钠、肌醇、dl-α-醋酸生育酚、醋酸维生素A、烟酰胺、D-泛酸钙、胆钙化醇、氰钴胺、植物甲萘醌、盐酸硫胺素、核黄素、盐酸吡哆醇、叶酸、D-生物素、牛磺酸、叶黄素、氯化胆碱、L-肉碱、核苷酸，
本发明的另一优选方案是，维生素各组分的重量份比例为， 48.95:2.48:3.21:0.15:0.69:0.49:0.003:0.05:0.38:0.11:1.44:0.15 :0.24:0.02:7.96:0.88:25.22:0.98：5.83。
本发明的另一优选方案是，所述矿物质由以下成分混合而成：矿物质预混料：柠檬酸钠、碳酸钙、柠檬酸钾、磷酸三钙、氯化钾、硫酸镁、硫酸亚铁、硫酸锌、亚硒酸钠、硫酸铜、硫酸锰、碘化钾。
本发明的另一优选方案是，所述矿物质里各成分的重量配比为： 22.2：25.1：1.9：1.2：37.1：7.8：2.3：0.93：0.09：0.71：0.031： 0.018。
绵羊奶是一种营养完全的食品，含有丰富的营养成分。绵羊奶的脂肪球颗粒小，中短链脂肪酸含量高更易于被人体消化吸收，另外，绵羊奶还含有丰富的乳钙，天然高含量的叶酸和维生素B12、天然含有更高含量的乳铁蛋白、母乳低聚糖(绵羊奶中天然母乳低聚含量高于牛奶和山羊奶)等，因此绵羊奶具有更多营养，更好消化吸收的优势。而本发明从整体上使绵羊奶粉基本上从营养上和功能上接近母乳。为婴幼儿生长和发育提供了全新的保障方案。
婴幼儿肠胃处于发育阶段，消化吸收及屏障保护等功能尚未健全，过剩营养物质难以消化，吸收消化及自身调节能力较弱，由于食物搭配不科学，引起“上火”。因为婴儿胃肠道发育不够成熟，酶的活性较低，但营养需要相对地多，胃肠道负担重，另外婴儿时期神经、内分泌、循环系统及肝、肾功能发育均未成熟，调节机能较差，很容易产生腹泻。如今，环境不良，滥用抗生素，先天遗传以及婴幼儿本身处于快速生长阶段，6岁以前被称为“生理性免疫功能低下状态”，因此，宝宝抵抗力很差，很容易生病。现在大部分婴幼儿配方产品暂时只停留在追求单个或几个营养素的高含量强化或适宜配比，且大部分婴幼儿配方奶粉 (包括婴幼儿配方羊奶粉)含有牛奶蛋白成分，牛奶中的某些蛋白质如α-s1酪蛋白和β-乳球蛋白是目前公认的过敏原，很容易造成婴幼儿过敏，其他低聚糖和脂肪酸的选择也不够精准，使宝宝免疫力下降，消化不良，上火以及容易腹泻。本发明通过调节FOS和GOS的配比，并且添加一种母乳低聚糖，组成肠道动力组合，有助于婴幼儿的肠道健康，促进体内的益生菌的生长繁殖，改善婴幼儿肠道微生态，母乳低聚糖由于含有和肠道表皮细胞表面受体类似的结构，通过竞争性抑制，直接结合于病原微生物和毒素表面，阻止其与肠道上皮细胞的结合。另一些则结合到消化道粘膜上皮细胞的受体上，阻止病原微生物或毒素与肠道上皮细胞的受体结合，从而防止感染的发生。还有的母乳低聚糖具有滋养功能，通过刺激肠道有益细菌的生长，间接抑制有害细菌。以保持肠道的生态平衡。生物学功能检测其主要表现为：①有利于肠道内双歧杆菌的增殖，本发明喂养的婴幼儿其肠道内双歧杆菌的数量远远高于普通配方食品喂养的婴幼儿；②抑制致病菌的生长，HMO能抑制肺炎链球菌、致肠病性大肠杆菌、单核细胞增多性李斯特氏菌、空肠弯曲杆菌、霍乱弧菌、绿脓假单胞菌、大肠杆菌、绿脓假单胞菌等致病菌的生长，同时对一些病毒和毒素也能起到一定的抑制作用，另外肠道内有益菌(双歧杆菌和乳杆菌)的增殖，会代谢产生乳酸和醋酸降低肠道内pH值，肠道内低的pH值也会抑制致病菌的生长；③可阻碍HIV-1从母体至婴儿的传递母乳内高含量的非3’-唾液酸乳糖HMO能有效保护婴儿免受来自母乳 HIV的感染；④预防坏死性小肠结肠炎(NEC)，NEC是早产儿较易发生的一种疾病，且对于早产低体质量婴儿来说其发生率高达10％，实验结果同时也证明婴幼儿配方食品内最常用的低聚半乳糖(GOS)不具有预防NEC的作用，而本发明中的低聚糖(disialyllacto-N-tetraose)具有预防小鼠NEC的作用；⑤低聚糖有预防婴幼儿腹泻的作用，降低婴幼儿腹泻的发生率。
具体实施方式
以下结合具体实施例对本发明作进一步的说明，本发明的保护范围并不仅限于这些实施例。
实施例1
一种婴幼儿配方绵羊奶粉，含有如下重量份配比的成分：全脂绵羊乳2700份，绵羊脱盐乳清粉120份，乳糖260份，植物油110份，低聚果糖12.8份、低聚半乳糖23份、DHA(二十二碳六烯酸)4.4份、ARA(花生四烯酸)6.5份、维生素5份、矿物质11.9份。
所述维生素为以下成分混合而成：L-抗坏血酸钠、肌醇、dl-α-醋酸生育酚、醋酸维生素A、烟酰胺、D-泛酸钙、胆钙化醇、氰钴胺、植物甲萘醌、盐酸硫胺素、核黄素、盐酸吡哆醇、叶酸、D-生物素、牛磺酸、叶黄素、氯化胆碱、L-肉碱、核苷酸，
其中，维生素各组分的重量份比例为， 48.95:2.48:3.21:0.15:0.69:0.49:0.003:0.05:0.38:0.11:1.44:0.15 :0.24:0.02:7.96:0.88:25.22:0.98：5.83。
所述矿物质由以下成分混合而成：矿物质预混料：柠檬酸钠、碳酸钙、柠檬酸钾、磷酸三钙、氯化钾、硫酸镁、硫酸亚铁、硫酸锌、亚硒酸钠、硫酸铜、硫酸锰、碘化钾。
其中，矿物质里各成分的重量配比为：22.2：25.1：1.9：1.2：37.1： 7.8：2.3：0.93：0.09：0.71：0.031：0.018。
上述实施例为本发明的实施方式，但本发明的实施方式并不受上述实施例的限制，其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化，均应为等效的置换方式，都包含在本发明的保护范围之内。
Claims (7)
1.一种婴幼儿配方绵羊奶粉，其特征在于，含有如下重量份配比的成分：全脂绵羊乳2200-3000份，绵羊脱盐乳清粉50-220份，乳糖200-320份，植物油80-140份，低聚果糖10-14份、低聚半乳糖19-26份、母乳低聚糖25-40份，DHA(二十二碳六烯酸)3.5-5份、ARA(花生四烯酸)4.5-8.5份、维生素4-6份、矿物质10-13份。
2.根据权利要求1所述的婴幼儿配方绵羊奶粉，其特征在于，含有如下重量份配比的成分：全脂绵羊乳2500-2800份，绵羊脱盐乳清粉100-150份，乳糖240-280份，植物油100-120份，低聚果糖12-13份、低聚半乳糖20-24份、DHA(二十二碳六烯酸)4-4.5份、ARA(花生四烯酸)5-7份、维生素4-6份、矿物质11-12份。
3.根据权利要求2所述的婴幼儿配方绵羊奶粉，其特征在于，含有如下重量份配比的成分：全脂绵羊乳2700份，绵羊脱盐乳清粉120份，乳糖260份，植物油110份，低聚果糖12.8份、低聚半乳糖23份、DHA(二十二碳六烯酸)4.4份、ARA(花生四烯酸)6.5份、维生素5份、矿物质11.9份。
4.根据权利要求1-3任意一项权利要求所述的婴幼儿配方绵羊奶粉，其特征在于，所述维生素为以下成分混合而成：L-抗坏血酸钠、肌醇、dl-α-醋酸生育酚、醋酸维生素A、烟酰胺、D-泛酸钙、胆钙化醇、氰钴胺、植物甲萘醌、盐酸硫胺素、核黄素、盐酸吡哆醇、叶酸、D-生物素、牛磺酸、叶黄素、氯化胆碱、L-肉碱、核苷酸。
5.根据权利要求4所述的婴幼儿配方绵羊奶粉，其特征在于，维生素各组分的重量份比例为，48.95:2.48:3.21:0.15:0.69:0.49:0.003:0.05:0.38:0.11:1.44:0.15:0.24:0.02:7.96:0.88:25.22:0.98：5.83。
6.根据权利要求1-3任意一项权利要求所述的婴幼儿配方绵羊奶粉，其特征在于，所述矿物质由以下成分混合而成：矿物质预混料：柠檬酸钠、碳酸钙、柠檬酸钾、磷酸三钙、氯化钾、硫酸镁、硫酸亚铁、硫酸锌、亚硒酸钠、硫酸铜、硫酸锰、碘化钾。
7.根据权利要求6所述的婴幼儿配方绵羊奶粉，其特征在于，所述矿物质里各成分的重量配比为：22.2：25.1：1.9：1.2：37.1：7.8：2.3：0.93：0.09：0.71：0.031：0.018。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011548938.9A CN114668044A (zh) | 2020-12-24 | 2020-12-24 | 一种婴幼儿配方绵羊奶粉 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011548938.9A CN114668044A (zh) | 2020-12-24 | 2020-12-24 | 一种婴幼儿配方绵羊奶粉 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114668044A true CN114668044A (zh) | 2022-06-28 |
Family
ID=82070720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011548938.9A Pending CN114668044A (zh) | 2020-12-24 | 2020-12-24 | 一种婴幼儿配方绵羊奶粉 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114668044A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104996576A (zh) * | 2015-08-28 | 2015-10-28 | 海普诺凯营养品有限公司 | 一种婴幼儿羊奶粉及其制备方法 |
| CN105532883A (zh) * | 2015-12-21 | 2016-05-04 | 海普诺凯营养品有限公司 | 一种婴幼儿用配方羊奶粉及其制备方法 |
| CN110063372A (zh) * | 2018-01-23 | 2019-07-30 | 天津澳斯乳业有限公司 | 一种婴幼儿配方羊奶粉及其生产方法 |
| CN110074190A (zh) * | 2019-05-28 | 2019-08-02 | 黑龙江贝特佳营养食品有限公司 | 一种用脱脂羊奶粉生产的婴幼儿配方羊奶粉 |
-
2020
- 2020-12-24 CN CN202011548938.9A patent/CN114668044A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104996576A (zh) * | 2015-08-28 | 2015-10-28 | 海普诺凯营养品有限公司 | 一种婴幼儿羊奶粉及其制备方法 |
| CN105532883A (zh) * | 2015-12-21 | 2016-05-04 | 海普诺凯营养品有限公司 | 一种婴幼儿用配方羊奶粉及其制备方法 |
| CN110063372A (zh) * | 2018-01-23 | 2019-07-30 | 天津澳斯乳业有限公司 | 一种婴幼儿配方羊奶粉及其生产方法 |
| CN110074190A (zh) * | 2019-05-28 | 2019-08-02 | 黑龙江贝特佳营养食品有限公司 | 一种用脱脂羊奶粉生产的婴幼儿配方羊奶粉 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102186463B (zh) | 促进健康发育与生长的营养组合物 | |
| AU2007253309B2 (en) | Maternal supplement | |
| CN108029768A (zh) | 一种含乳铁蛋白和益生菌的婴幼儿配方奶粉及其制备方法 | |
| CN111616232A (zh) | 一种促进骨骼生长的儿童奶粉及其制备方法 | |
| CN112535283A (zh) | 一种全营养配方粉 | |
| CN104206539A (zh) | 一种益生菌婴幼儿奶粉 | |
| CN106615690A (zh) | 改善宠物贫血症状的营养膏、制备方法及其应用 | |
| CN103096734A (zh) | 营养组合物 | |
| CN112998080A (zh) | 一种添加蛋黄磷脂、大豆磷脂和乳磷脂的婴幼儿配方奶粉 | |
| CN111587923A (zh) | 一种含有唾液酸的婴儿配方食品及制备方法 | |
| CN114128767B (zh) | 含有母乳低聚糖的乳蛋白部分水解低致敏性婴儿配方食品 | |
| CN105076417A (zh) | 一种具有护肠功能的配方奶粉及制备方法 | |
| CN107467193B (zh) | 一种以羊奶为基础的粉剂全营养特殊医学用途配方食品及其制备方法 | |
| CN106889327A (zh) | 一种乳猪奶粉及其制备方法 | |
| CN106615689A (zh) | 一种提高弱僵猪生产性能的肠道保健剂及其制备方法和使用方法 | |
| CN117481199A (zh) | 促进生长发育的早产/低出生体重婴儿食品及其制备方法与应用 | |
| CN108157512A (zh) | 一种强化6~12个月婴幼儿胃肠道功能的配方奶粉 | |
| WO2013122616A1 (en) | Methods for making milk-like beverages | |
| CN105053213A (zh) | 提高婴幼儿抵抗力的奶粉及生产方法 | |
| CN114668044A (zh) | 一种婴幼儿配方绵羊奶粉 | |
| CN116548608B (zh) | 一种儿童全营养配方粉及其制备方法和应用 | |
| CN116349734A (zh) | 一种促进消化吸收的肠道型婴儿配方奶粉及其制备方法 | |
| CN117598475A (zh) | 一种成人特殊医学用途全营养配方食品及其制备方法 | |
| CN114568527A (zh) | 改善肠道微环境健康的母乳化婴幼儿配方粉及其应用 | |
| CN117084403A (zh) | 一种营养组合物及其制备方法和用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220628 |